1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Absolute concentrations (mmol/kg wet weight) of Lac, NAA, Cho, and Cr
Metabolite Control Group (n = 10) Neonatal Encephalopathy Infants (n = 17) P Values Normal/Mild Outcome (n = 10) Severe/Fatal Outcome (n = 7) Control Versus Normal/Mild Outcome Control Versus Severe/Fatal Outcome Normal/Mild Outcome Versus Severe/Fatal Outcome Lac 2.78 (0.83) 3.24 (1.25) 4.60 (3.20–12.08) .34 .01* .11 NAA 9.21 (1.29) 7.72 (1.46) 5.24 (2.58) .03* <.001* .03* Cho 4.39 (0.78) 3.62 (0.52) 2.60 (2.30–3.80) .02* .02* .14 Cr 10.94 (1.88) 9.07 (2.12) 7.93 (3.39) .05* .03* .41
Note:—Lac indicates lactate; NAA, N-acetylaspartate; Cho, choline; Cr, creatine.
* Denotes statistically significant differences between the groups. Values are mean (SD) and median (interquartile range) as appropriate.